Significance: This is the first genome-wide association study on neck or shoulder 47 pain. We have identified 3 genetic loci (an intergenic region in chromosome 17, the 48 FOXP2 gene in chromosome 7, and the LINC01572 gene in chromosome 16) that 49 are associated with neck or shoulder pain using the UK Biobank cohort, among 50 which the FOXP2 gene and the LINC01572 gene were weakly replicated by the 51
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Participants and the genetic information of cohorts 125
Discovery cohort -The UK Biobank (https://www.ukbiobank.ac.uk/) is a project 126 facilitating research into health and disease and involves over 500,000 participants 127 aged between 40-69 years old at recruitment. Participants completed a detailed 128 questionnaire which examined lifestyle, demographic factors, and clinical history. 129
Participants also underwent clinical measures and baseline body measurements 130 such as height and weight. Biological samples including urine, saliva, and blood 131 were also provided. The National Research Ethics Service granted ethical approval 132 to the UK Biobank (reference 11/NW/0382). The genetic information of 500,000 133 participants was released to approved researchers in March 2018. The 134 corresponding author of this paper was granted access to the genetic information 135 under UK Biobank application number 4844. Detailed quality control information 136 pertaining to these genotypes was described by Bycroft et al (27) . 137
Replication cohort 1 -Generation Scotland: Scottish Family Health Study (GS:SFHS) 138 is a multi-institutional, family-based cohort involving over 20,000 volunteer 139 participants aged between 18-98 years old at recruitment, who provided blood 140 samples from which DNA was extracted. Similarly, participants also completed 141 questionnaires to provide detailed phenotypic and sociodemographic information. 142
Clinical and biochemical measurements were also collected for the purpose of 143 research. Permission was obtained for linkage of research data to routine health 144 data in the form of electronic health records (28, 29) . Ethical approval for GS:SFHS 145 was obtained from the Tayside Committee on Medical Research Ethics (on behalf of 146 the National Health Service) with reference Number 05/S1401/89. The genetic 147 information relating 20,000 participants was released to the corresponding author of this paper in March 2018 for pain-related research. Detailed quality control 149 information pertaining to these genotypes was described by Hall et al (30) . 150
Replication cohort 2 -The TwinsUK cohort is a UK nationwide registry of volunteer 151 same sex twins. It has recruited 14,274 registered twins aged between 16 and 98 152 years. Collection of data and biological materials commenced in 1992 and is ongoing. 153
During study participation, participants regularly complete health and lifestyle 154 questionnaires and visit collaborating clinics and hospitals for clinical evaluation. 155
Ethical approval was provided by the Research Ethics Committee at Guy's and St. 156 Thomas' NHS Foundation Trust. TwinsUK has the genetic information relating to 157 6,921 participants. Detailed quality control information pertaining to the genetic 158 information was described by Moayyeri et al (31) . 159
Phenotypic definitions on neck or shoulder pain 160
Discovery cohort -UK Biobank: Participants were offered a pain-related 161 questionnaire, which included the question: 'in the last month have you experienced 162 any of the following that interfered with your usual activities?'. The options were: 1. 163
Headache; 2. Facial pain; 3. Neck or shoulder pain; 4. Back pain; 5. Stomach or 164 abdominal pain; 6. Hip pain; 7. Knee pain; 8. Pain all over the body; 9. None of the 165 above; 10. Prefer not to say. Participants could select more than one option. (UK 166 Biobank Questionnaire field ID: 6159). 167
In this study, cases were defined as participants who reported having activity limiting 168 pain in the neck or shoulder in the past month (option 3), regardless of whether they 169 reported pain in other regions. The controls were defined as participants who chose 170 the 'None of the above' option. then the participants were asked ''Have you had this pain or discomfort for more than 174 3 months?''. If yes was selected once again, then they were asked ''Where is this 175 pain or discomfort?'' with options of 'Back pain', 'Neck or shoulder pain', 'Headache, 176 facial or dental pain', 'Stomach ache or abdominal pain', 'Pain in your arms, hands, 177 hips, legs or feet', 'Chest pain', and 'Other pain'. If a participant selected the 'Neck or 178 shoulder pain', then he/she was defined as a case. All other subjects were defined 179 as controls. 180
Replication cohort 2: TwinsUK: participants were asked 'In the past three months, 181 have you had pain in your neck or shoulders?' Those who answered 'Yes' were 182 defined as cases. Those who answered 'No' were defined as controls. Those with 183 missing answers were not included in the study. 184
Statistical Analysis 185
Discovery cohort -UK Biobank: BGENIE (https://jmarchini.org/bgenie/) was used as 186 the main GWAS software. Single nucleotide polymorphisms (SNPs) with imputation 187 INFO scores < 0.1, minor allele frequency (MAF) < 0.5% were removed, as well as 188
SNPs that failed Hardy-Weinberg tests P < 1.0 x 10 -6 . 189 BGENIE was used to perform association studies using linear association tests, 190 adjusting for age, sex, BMI, 9 population principle components, genotyping arrays, 191 and assessment centres. Chi-square testing was used to compare gender difference 192 between cases and controls. T-tests were used to compare age and BMI between 193 case and control groups using IBM SPSS 22 (IBM Corporation, New York). As is 194 standard in GWAS, SNP associations were considered significant when P < 5.0 x 10 -195 replication. These significant and independent SNPs were defined by FUMA with r 2 199 (linkage disequilibrium score) < 0.6 with any other significant SNPs. Post-GWAS analysis: This study used FUMA as a main annotation tool for viewing 213 and annotating GWAS results (33). It applied SNP functional annotations and 214 generated a corresponding GWAS Manhattan plot. 215 MAGMA v1.06 (integrated in FUMA) was used to perform gene-based association 216 analysis and gene-set analysis, both of which were generated from GWAS summary 217 statistics (34). For gene-based association analysis, all SNPs located in protein 218 coding genes are mapped to one of 19,123 protein coding genes. The default SNP-219 wise model (mean) was applied. We tested the joint association of all SNPs in the 220 gene with the phenotype by aggregating the SNP summary statistics to the level of 221 whole genes. In gene-set analysis, individual genes were aggregated to groups of elucidate the involvement of specific biological pathways or cellular functions in the 224 genetic aetiology of a phenotype. GTEx (also integrated in FUMA, 225 https://www.gtexportal.org/home/) provided the results of tissue expression analysis. 226
Genetic correlation analysis was also performed to identify genetic correlation 227 between neck or shoulder pain and 234 complex traits based on the online tool LD 228 hub v1.9.0 (http://ldsc.broadinstitute.org/ldhub/). Any P value less than 2.1 x 10 -4 229 (0.05/234) was considered statistically significant by Bonferroni adjusted testing. 230
231

RESULTS
232
GWAS Results 233
In the UK Biobank, 775,252 responses to all options were received for the specific 234 pain question. Of the 501,708 participants in the study, 123,061 participants reported 235 having experienced activity limiting pain in the neck or shoulder in the previous 236 month. 213,408 participants chose the 'None of the above' option which meant they 237 did not have activity limiting pain anywhere in the previous month. To create a 238 homogeneous dataset, we first removed samples according to their ancestry 239 information. In addition, those who were related to one or more others in the cohort 240 (a cut-off value of 0.044 in the generation of the genetic relationship matrix) and 241 those who failed quality control were also removed. The final number of those 242 included in the case group after the above exclusions was 53,994 (28,093 males, 243 25,901 females). 149,312 (71,480 males, 77,832 females) individuals were included 244 in the control group. After SNP quality control, there were 9,304,965 SNPs available 245 for GWAS analysis. Clinical characteristics of the case and control groups were 246 compiled (Table 1) . Age, sex, and BMI were all found to be significantly different (P < 247 0.001) between cases and controls. Three genetic loci including 4 significant and independent SNPs reached a GWAS significance of P < 5×10 -8 ( Figure 1 , Table 2 ). 249
The most significant locus was located in an intergenic region in chromosome 17. 250
The SNP from this location of highest significance was rs12453010 (P = 1.66 x 10 -10 ). 251
The second locus was found in the FOXP2 gene located in chromosome 7, and the 252 most significant SNP from this locus was rs34291892 (P = 2.38 x 10 -10 ). The third 253 locus was the LINC01572 gene located in chromosome 16, and the most significant 254 SNP in this locus was rs62053992 (P = 4.50 x 10 -10 ). The SNP heritability (liability 255 scale) from GCTA was 0.11+0.017. 256
These 4 significant and independent SNPs were tested for replication in GS:SFHS 257 and TwinsUK. Among 20,032 subjects in the GS:SFHS subjects, 19,632 had 258 complete relevant information. The whole-genome fastGWA results did not find any 259
SNPs with GWAS significance associated with neck or shoulder pain. 260 Figure S1 ). Among the 4 SNPs from the discovery cohort, 261 rs2049604 in the FOXP2 gene and rs62053992 in the LINC01572 gene were 262 replicated weakly (P = 0.0240 and 0.0202, respectively) ( Table 2) . Of the 6,921 263 individuals in TwinsUK with genetic information, 3,982 of them had valid relevant 264 information on phenotypes and covariates. None of the 4 SNPs were replicated in 265 the TwinsUK cohort (P > 0.05). 266
(Supplementary
Meta-analysis of the 4 significant and independent hits, combining UK Biobank, 267 GS:SFHS and Twins UK found that the significance of their associations was 268 increased ( Table 2) . 269
FUMA Analysis 270
In gene-based association analysis by MAGMA, 26 genes were found to be 271 associated with neck or shoulder pain, all of which are represented in Supplementary  272   Table S1 . The most significant gene was FOXP2 (P = 1.62 x 10 -11 ), which is located in chromosome 7. 274
In gene-set analysis conducted by MAGMA, 10,651 gene-sets were analysed using 275 the default competitive test model. None of these gene-sets met genome-wide 276 significance (P < 4.7 x 10 -6 (0.05/10651)). 277
Tissue expression analysis was conducted by GTEx, and the relationship between 278 tissue specific gene expression and genetic associations was tested by using the 279 average gene expression in each tissue type as a covariate. Two analyses were 280 carried out, one investigating 30 general tissue types ( Figure 2 ) and the other looking 281 at 53 specific tissue types ( Figure 3 ). Tissue expression analysis in 30 tissue types 282 found expression in brain tissue to be the most significant (P = 9.53 x 10 -5 ). Only 283 expression in brain and pituitary tissue reached significant values of P < 1.67 x 10 -3 284 (0.05/30). Tissue expression analysis of 53 specific tissue types by GTEx found 285 expression in the nucleus accumbens of the basal ganglia to be the most significant 286 (P = 3.55 x 10 -5 ). In addition, the top 6 significant associations were all from brain 287
tissues. 288
The genetic correlation analysis using the LD hub (v1.9.0) showed that symptoms of 289 depression had the largest significant and positive genetic correlation with neck or 290 shoulder pain (rg = 0.5522, P = 3.41 x 10 -30 ), followed by insomnia (rg = 0.5377, P = 291 1.21 x 10 -21 ). It was also found that the age at which they have their first child had 292 the most significant and negative genetic correlations with neck or shoulder pain (rg 293 = -0.4812, P = 8.95 x 10 -37 ), followed by college completion (rg = -0.4706, P = 7.26 x 294 10 -26 ). All the phenotypes with significant genetic correlation with neck or shoulder 295 pain are shown in Table 3 . 296
We have performed a GWAS on neck or shoulder pain using the UK Biobank 299 resource and found 3 loci that have reached genome-wide significance (P <0.05 × 300 10 -8 ). They are the FOXP2 gene in chromosome 7, the LINC01582 gene in 301 chromosome 16 and an intergenic area in chromosome 17. In the replication stage, 302 the FOXP2 and LINC01582 loci were weakly supported by the GS:SFHS cohort, but 303 not by TwinsUK. 304
FOXP2 belongs to the forkhead-box transcription factor family and encodes a 715 305 amino acid long transcription factor (35). It may have 300-400 transcription targets, 306
and has a forkhead/winged helix binding domain with 2 polyglutamine tracts adjacent 307 to each other due to a mixture of CAG and CAA repeats (36, 37) . FOXP2 is a gene 308
shown to be vital in the neural mechanisms underpinning the development of speech 309 and language. A previous study described a family with developmental verbal 310 dyspraxia, where affected individuals had a loss of function mutation in the FOXP2 311 gene (38). Affected individuals in the family had difficulty with the selection and 312 sequencing of fine orofacial muscular movements needed to articulate words, as well 313 as deficits in language and grammatical skills. FOXP2 also plays a role in regulating 314 'hub' genes Dlx5 and Syt4 in animal models, which are important for brain 315 development and function (39) (40) (41) . The mutations in the FOXP2 gene were also 316 associated with decreased grey matter in the cerebellum (42). 317
Notably, FOXP2 is expressed in several regions of the brain, namely the basal 318 ganglia, locus coeruleus, parabrachial nucleus, and thalamus. All of these regions 319 have been previously implicated in the modulation of pain (43-46), and also concur 320 with the tissue expression analysis (Figure 2, Figure 3 ) which suggests that the 321 central nervous system modulates neck or shoulder pain. A recent GWAS study studies into the location and function of the transcription targets of FOXP2 would 324 also provide valuable insight. 325
The LINC01572 gene in chromosome 16 was also replicated in this study, with 326 rs62053992 having the P value at 4.5×10 -8 in the discovery cohort and at 0.02 in the 327 GS:SFHS. The gene is 384kb long, and was recently suggested to be related with 328 polycystic ovary syndrome (48). However, studies of this gene have been very 329
limited. Further replication evidence should be sought to confirm its role in neck or 330 shoulder pain. Although the locus in chromosome 17 was not replicated, it was the 331 most significantly associated in the discovery cohort with rs12453010 having the 332 lowest P value of 1.66 x 10 -11 . Analysis of this locus is also difficult as it is a gene 333 desert area. The nearest neighbouring gene is CA10, which encodes a protein 334 belonging to the carbonic anhydrase family and is responsible for catalysing the 335 hydration of carbon dioxide. It is also thought to contribute to central nervous system 336 development particularly in the brain (49). 337
The results of the meta-analysis of the 4 significant and independent SNPs 338 combining 3 cohorts suggested that the loci identified by the UK Biobank cohort were 339 supported by the GS:SFHS and TwinsUK. It is likely that the sample size in the 340 TwinsUK (N= 3,982) was too small to replicate the loci for such a heterogeneous 341 phenotype as neck or shoulder pain. In particular, for the 4 SNPs chosen for 342 replication, the power to achieve a P value < 0.05 in the given TwinsUK sample 343 ranged between 11.6% to 15.8% (50). 344
The SNP heritability of neck or shoulder pain was 0.11. This is similar to that of back 345 pain (0.11), greater than knee pain (0.08), and less than: hip pain (0.12), stomach or 346 abdominal pain (0.14), headache (0.21), facial pain (0.24), and pain all over the body 347 (0.31) (51). Further, the genetic correlation matrix among 8 pain phenotypes in the UK Biobank showed that the neck or shoulder pain and back pain shared the highest 349 genetic correlation (rg = 0.83) (51). 350
The genetic correlation analysis results were perhaps to be expected. Like knee pain 351 and back pain, which have been shown to be positively correlated with depression 352 and neuroticism (51), neck or shoulder pain was correlated genetically and positively 353 with some mental health and personality phenotypes. We also identified that neck or 354 shoulder pain was genetically and negatively correlated with the age at which they 355 have their first child, college completion, and years of schooling. This means that 356 those who were older when they had their first child, those with more years of 357 schooling, and those with completed college education were less likely to report neck 358 or shoulder pain. These factors could be related to a number of factors including 359 lifestyle, deprivation levels, and occupation. It is interesting to note that males are 360 more likely to report neck or shoulder pain than females in the UK Biobank 361 population. This is matched with the fact that males are more likely to have 362 strenuous occupations. However, we should note, in general, female sex is a risk 363 factor for neck or shoulder pain. 364
The primary limitation of this study is that different (albeit similar) case and control 365 definitions were used in the discovery and replication cohorts. This was a 366 consequence of the pre-determined phenotypic information that was present in the 367 relevant cohorts. We defined neck or shoulder pain cases and controls based on the 368 responses by UK Biobank participants to a specific pain question. This question 369 focused on neck or shoulder pain occurrence during the previous month that was 370 sufficient to cause interference with activity. The severity, frequency, and exact 371 location of the neck or shoulder pain were not documented. Hence, our phenotyping 372 should be considered as broadly defined. In the GS:SFHS and Twins UK cohorts, the disease status of participants was also self-reported, while cases were those 374 who having neck or shoulder pain over the past 3 months, controls were those who 375 could have neck or shoulder pain less than 3 months or have pain in other body sites. 376
While in the UK Biobank, controls were defined as pain free for the past month. 377
Differences between (albeit similar) the case and control definitions could have a 378 negative impact on replication of the results while this impact is hard to evaluate 379
Differences between the case and control definitions could have a negative impact 380 on replication of the results although this impact would be hard to evaluate. There 381 could also be some cases who report neck or shoulder pain as a result of underlying 382 causes such as cancer and osteoarthritis in the neck and shoulder areas. Their 383 impact to the results would be very limited due to the small numbers. 384
In summary, we have identified 3 loci of genome-wide significance (P < 5×10 -8 ) 385 associated with neck or shoulder pain in the UK Biobank dataset using a GWAS 386 approach. Two of these loci were replicated weakly in the GS:SFHS cohort. 387
Identification of these loci now provides a foundation for future work into 388 understanding genetic roles and aetiology in neck or shoulder pain. 389
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